@article{AOJ5605,
author = {Dongquan Shi and Nicholas D. Clement and Rameah Bhonde and Shiro Ikegawa and Vasco V. Mascarenhas and Berardo Di Matteo and Pier Francesco Indelli and Nikolaos Kourkoumelis and E. Carlos Rodríguez-Merchán and Mohsen Sheykhhasan and Freddie H. Fu and Marco Aurélio Vaz and Jian Kong and Boris Gabin Kingue Azantsa and Chuan Ye and Farzin Halabchi and Stephen M. Cornish and Leslie R. M. Hausmann and André Luiz Siqueira Campos and Carlos César Lopes de Jesus and Christian Jorgensen and Elena M. Ilieva and Weiguo Wang and Laura Villarreal Martínez and Hyochol Ahn and Ivan V. Shirinsky and Corjena Cheung and Gunnar Knutsen and Wolf Petersen and Nancy E. Lane and Hong Cai and Wei Xu and Jian Wu and Jun Lu and Yingze Zhang and Qing Jiang},
title = {Society for translational medicine-expert consensus on the treatment of osteoarthritis},
journal = {Annals of Joint},
volume = {4},
number = {0},
year = {2020},
keywords = {},
abstract = {Osteoarthritis (OA), also known as osteoarthrosis, is the most prevalent form of joint pathology. It is attributed to diverse causes like joint injury, obesity, aging, and genetic predisposition. The result is the degeneration of the articular cartilage, the subchondral bone, and the entire joint organ. The articular cartilage destruction, typical of OA, is associated with joint space narrowing and periarticular hypertrophic changes. Chronic knee pain significantly affects quality of life (1). People suffering from OA are often confused about the management of their condition. Healthcare professionals must provide support and clear advice on the possible ways to regulate symptoms like pain and decreased physical function, which have an impact on self-efficacy and social engagement.},
issn = {2415-6809}, url = {https://aoj.amegroups.org/article/view/5605}
}